RESEARCH ARTICLE
Acute Sclerokeratitis After Cataract Surgery: Treatment with Topical Use of Cyclosporine – A
K Doulas*, C Pantazopoulou, D Feretis
Article Information
Identifiers and Pagination:
Year: 2008Volume: 2
First Page: 31
Last Page: 33
Publisher ID: TOOPHTJ-2-31
DOI: 10.2174/1874364100802010031
Article History:
Received Date: 16/1/2008Revision Received Date: 20/2/2008
Acceptance Date: 21/2/2008
Electronic publication date: 8/3/2008
Collection year: 2008
open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.5/) which permits unrestrictive use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
We would like to report an interesting case of acute sclerokeratitis following cataract surgery treated with topical use of Cyclosporine-A. A 61-year old woman with a past history of scleritis in her right eye had an uneventful phaco surgery in her right eye for cataract removal via a corneoscleral incision. Eight months after the initial surgery the patient had a sudden decrease in her visual acquity in the right eye with marked inflammatory signs in the sclera and cornea adjacent to the entry-site of the phaco surgery. Initially the patient was treated with systemic corticosteroids but due to serious side effects topical cyclosporine-A was added instead. Five months later the patient has a significant improvement in terms of visual acquity with marked reduction in the inflammatory signs both in sclera and corneal tissue. We think that topical Cyclosporine-A with its potent immunomodulating effects seems to be of benefit in those cases where systemic corticosteroids are contraindicated or have serious side-effects.
